Synaptogenix

-$0.26 (-3.82%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Synaptogenix and other ETFs, options, and stocks.

About SNPX

Synaptogenix, Inc. operates as a biopharmaceutical company, which engages in the development of a product platform based upon a drug candidate called Bryostatin-1 used for the treatment of Alzheimer’s disease. The firm also evaluates potential therapeutic applications of Bryostatin-1 for other neurodegenerative or cognitive diseases and dysfunctions.

CEO
Alan J. Tuchman
Employees
—
Headquarters
New York, New York
Founded
2012

SNPX Key Statistics

Market cap
44.54M
Price-Earnings ratio
—
Dividend yield
—
Average volume
65.96K
High today
$7.00
Low today
$6.42
Open price
$6.93
Volume
76.26K
52 Week high
$14.50
52 Week low
$3.79
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure